A treatment for narcolepsy could help people give up smoking, according to a
patent filed by pharmaceuticals giant Glaxo Wellcome (WO 99/25355). Glaxo鈥檚
researchers have found that a compound developed for the treatment of
narcolepsy-cataplexy syndrome and depression has the surprising effect of
countering addiction to nicotine. The compound, containing complex fluorophenyl
groups, can either be administered by mouth or injected. Glaxo admits it is not
yet sure how the drug works, but believes it affects one particular group of
neurotransmitters.
More from New Scientist
Explore the latest news, articles and features
Physics
The surprising upsides of living in a reality that repeats for eternity
Features
Life
Female clones created from the blood of male mice
News
91色情片
Postbiotic could reduce the risk of brain damage after a concussion
News
Humans
Did humans evolve to be active throughout the day and night?
News
Popular articles
Trending New Scientist articles